De-risking drug formulation with AI predictive modelling
AI predictive modelling is helping to reduce trial-and-error in formulation development by combining molecular data with targeted experimental validation. We explore how this approach can prioritise high-probability candidates, cut iteration and de-risk, ultimately accelerating therapy delivery to patients.
